CERTANIA Acquires Bioarray Genetic Diagnosis
July 9, 2025
CERTANIA, a Munich-based Testing, Inspection and Certification (TIC) group, has acquired Spanish genetic diagnostics lab Bioarray, which will join CERTANIA’s global network. Bioarray — headquartered in Elche (Alicante) — will continue to be led by cofounder Andrés Antón Salas and will leverage CERTANIA’s platform to expand its genomic diagnostics and research services internationally.
- Buyers
- CERTANIA Holding GmbH
- Targets
- Bioarray Genetic Diagnosis (Bioarray S.L.)
- Industry
- Healthcare Services
- Location
- Alicante, Spain
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CERTANIA Group (backed by GREENPEAK Partners) Adds Biotec GmbH
August 20, 2024
Environmental Services
CERTANIA Holding GmbH has welcomed Biotec GmbH, a German consultancy and environmental laboratory specializing in microbiological and air hygiene, into its Testing, Inspection & Certification group. The Biotec management team retains operational independence while joining the CERTANIA platform (backed by GREENPEAK Partners) to expand environmental hygiene and laboratory services across CERTANIA’s network.
-
CERTANIA Acquires Alphalytik Pharmaservice GmbH
September 4, 2024
Healthcare Services
CERTANIA, a Munich-based testing, inspection and certification group, has acquired Alphalytik Pharmaservice GmbH, a Berlin-headquartered specialist in pharmaceutical analytical testing. The acquisition brings Alphalytik's GMP/FDA-approved stability testing, method development and release testing capabilities into the CERTANIA platform to expand the group's pharma testing services and support growth.
-
CERTANIA Acquires Triskelion
February 28, 2024
Healthcare Services
Triskelion, an accredited analytical laboratory headquartered in Utrecht, has joined CERTANIA Holding GmbH, a growing Testing, Inspection & Certification (TIC) group. The move — supported by GREENPEAK Partners — positions Triskelion to expand its analytical and consulting services across food safety, chemical and early-clinical biopharma markets while benefitting from CERTANIA's platform resources.
-
CERTANIA Holding GmbH Acquires TAZ GmbH
May 22, 2024
Industrial Services
CERTANIA Holding GmbH has added TAZ GmbH, an Aichach-based materials testing and calibration laboratory, to its Testing, Inspection & Certification group. TAZ will remain independent while leveraging CERTANIA's resources to expand capabilities in metallography, fracture analysis and calibration services for industries including automotive, aerospace and medical.
-
CERTANIA Acquires RAS-SCI
November 15, 2024
Logistics & Distribution
Munich-based CERTANIA, a Testing, Inspection & Certification (TIC) group, has acquired RAS-SCI, a Bromley-headquartered provider of supply chain assurance and compliance solutions. The deal brings RAS-SCI's proprietary technology and 450+ auditor network into the CERTANIA platform to expand capabilities in retail and grocery supply-chain assurance and to accelerate growth into mainland Europe; RAS-SCI's founders and directors will remain involved in the business.
-
Matrix Medical Network Acquires Biocerna
October 2, 2020
Healthcare Services
Matrix Medical Network acquired Biocerna, a CLIA-certified and CAP-accredited clinical laboratory based in Fulton, Maryland, to integrate in-house diagnostic and COVID-19 testing capabilities. The acquisition expands Matrix's ability to deliver timely testing services to its network of clinicians and mobile health clinics, supporting employer testing, clinical trial support, and other client-facing diagnostic services.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.